amycretin Novo Nordisk, which makes Wegovy and Ozempic, is testing this experimental, unimolecular drug to target two hormone pathways, GLP-1 and amylin, a hormone that helps control hunger
Aitken-Buck HM, Krause J, Zeller T, Jones PP, Lamberts RR
Future studies are certainly warranted to extensively characterize the phenotype and neural anatomical projection fields of the GLP-1-/amylin-activated DVC neurons, as well as the role of astrocytes and microglia 67,68 in mediating the enhanced intake and body weight suppressive effects of amylin + GLP-1 combinatorial therapy
They can provide personalised guidance based on your individual health needs and conditions while ensuring that any changes do not interfere with existing treatments or medications you may be on
Supplementation strategy Reduced food intake means reduced micronutrient intake